SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form CERT - Certification by an exchange approving securities for listing:
SEC Accession No. 0001354457-20-000186
Filing Date
2020-05-07
Accepted
2020-05-07 11:07:10
Documents
1
Effectiveness Date
2020-05-07

Document Format Files

Seq Description Document Type Size
1 8A_Cert_AYLA.PDF CERT 123066
  Complete submission text file 0001354457-20-000186.txt   170691
Mailing Address 1313 N. MARKET STREET SUITE 5100 WILMINGTON DE 19801
Business Address 1313 N. MARKET STREET SUITE 5100 WILMINGTON DE 19801 (857) 444-0553
Ayala Pharmaceuticals, Inc. (Filer) CIK: 0001797336 (see all company filings)

IRS No.: 823578375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CERT | Act: 34 | File No.: 001-39279 | Film No.: 20855159
SIC: 2836 Biological Products, (No Diagnostic Substances)